{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:28:04Z","timestamp":1787041684192,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018637","name":"Yunnan Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005147","name":"Yunnan Applied Basic Research Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010971","name":"Yunnan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119114","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:05:29Z","timestamp":1782774329000},"page":"119114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and anti-SARS-CoV-2 activity of vilazodone derivatives as METTL3 inhibitors"],"prefix":"10.1016","volume":"317","author":[{"given":"Xiao-Long","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Rui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Zhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Dong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo-Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Tang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119114_bib1","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cell.2021.02.013","article-title":"Antivirals with common targets against highly pathogenic viruses","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119114_bib2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.cell.2020.08.021","article-title":"Emerging pandemic diseases: how we got to COVID-19","volume":"182","author":"Morens","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119114_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-025-00662-x","article-title":"Acute SARS-CoV-2 infection","volume":"11","author":"Sherman","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2026.119114_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","article-title":"Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond","volume":"155","author":"Chaudhuri","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119114_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119114_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116442","article-title":"Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics","volume":"271","author":"Lu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119114_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119114_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-021-01356-0","article-title":"The m(6)A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis","volume":"20","author":"Uddin","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.119114_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103513","article-title":"The development of small molecules targeting methyltransferase-like 3","volume":"28","author":"Li","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119114_bib10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/s41556-022-00968-y","article-title":"METTL3 preferentially enhances non-m(6)A translation of epigenetic factors and promotes tumourigenesis","volume":"24","author":"Wei","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119114_bib11","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2026.119114_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119114_bib13","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jmedchem.2c01601","article-title":"METTL3 from target validation to the first small-molecule inhibitors: a medicinal chemistry journey","volume":"66","author":"Fiorentino","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119114_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126934","article-title":"Emerging roles of biological m(6)A proteins in regulating virus infection: a review","volume":"253","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119114_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s11658-023-00490-5","article-title":"N6-methyladenosine modification\u2014a key player in viral infection","volume":"28","author":"Zhang","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2026.119114_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13567-024-01424-5","article-title":"When animal viruses meet N(6)-methyladenosine (m(6)A) modifications: for better or worse?","volume":"55","author":"Wang","year":"2024","journal-title":"Vet. Res."},{"key":"10.1016\/j.ejmech.2026.119114_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109091","article-title":"METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection","volume":"35","author":"Li","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.119114_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41422-020-00465-7","article-title":"The m(6)A methylome of SARS-CoV-2 in host cells","volume":"31","author":"Liu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.119114_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.15528","article-title":"N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression","volume":"5","author":"Tirumuru","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119114_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.chom.2016.10.002","article-title":"Dynamics of human and viral RNA methylation during zika virus infection","volume":"20","author":"Lichinchi","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.119114_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41586-020-03135-1","article-title":"m(6)A RNA methylation regulates the fate of endogenous retroviruses","volume":"591","author":"Chelmicki","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119114_bib22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1101\/gad.348320.121","article-title":"Targeting the m(6)A RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication","volume":"35","author":"Burgess","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2026.119114_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114942","article-title":"Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71","volume":"246","author":"Salerno","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119114_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2026.106376","article-title":"Onvansertib and vilazodone inhibit SARS-CoV-2 replication via suppression of METTL3 RNA-m(6)A enzymatic activity","volume":"248","author":"Zhang","year":"2026","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119114_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4088\/JCP.11r06984","article-title":"Vilazodone: clinical basis for the US food and drug Administration's approval of a new antidepressant","volume":"72","author":"Laughren","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejmech.2026.119114_bib26","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1021\/acs.oprd.2c00206","article-title":"Development of a robust and scalable process for the large-scale preparation of vilazodone","volume":"26","author":"Zhou","year":"2022","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2026.119114_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","article-title":"Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases","volume":"63","author":"Wang","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2026.119114_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2026.119114_bib29","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119114_bib30","doi-asserted-by":"crossref","DOI":"10.1063\/5.0018516","article-title":"Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS","volume":"153","author":"Pall","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2026.119114_bib31","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1021\/j100308a038","article-title":"The missing term in effective pair potentials","volume":"91","author":"Berendsen","year":"1987","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ejmech.2026.119114_bib32","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2026.119114_bib33","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:05:50Z","timestamp":1787040350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0223523426005593"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119114","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and anti-SARS-CoV-2 activity of vilazodone derivatives as METTL3 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119114"}}